Vector-borne diseases (VBDs) pose a significant public health challenge in India, affecting millions annually. The country's diverse ecosystem and climatic conditions provide an ideal environment for the proliferation of various vectors, leading to the widespread prevalence of these diseases.
VBDs, including malaria, dengue, and chikungunya, account for more than 17% of all infectious diseases in India, causing substantial morbidity and mortality. The economic burden induced by VBDs is considerable, with direct and indirect costs affecting both the healthcare system and the affected individuals.
Despite several control measures, the elimination of VBDs remains a formidable challenge due to factors such as inadequate surveillance, lack of public awareness, and socio-economic disparities. Additionally, climate change and urbanization contribute to the increased incidence and geographical spread of these diseases.
Healthcare professionals play a crucial role in combating VBDs through early diagnosis, appropriate treatment, and patient education. They are instrumental in implementing preventive measures, conducting research, and advocating for policy changes to mitigate the impact of these diseases.
In conclusion, the burden of VBDs in India is significant and complex, necessitating a multi-faceted approach for effective control. Healthcare professionals are at the forefront of this battle, and their role is pivotal in reducing the disease burden. Continued efforts towards improving surveillance, enhancing public awareness, and fostering research and development are essential to tackle the challenge of VBDs in India.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation